Reuters logo
4 years ago
US appeals court says Watson did not infringe Cephalon patents
February 14, 2013 / 5:30 PM / 4 years ago

US appeals court says Watson did not infringe Cephalon patents

1 Min Read

NEW YORK, Feb 14 (Reuters) - A U.S. appeals court reversed part of a ruling in favor of Watson Pharamaceutials over Cephalon in patent lawsuit over the cancer drug Fendora.

The U.S. Court of Appeals for the Federal Circuit upheld, however, the lower court's ruling that Watson did not infringe Cephalon's patents.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below